References
- American Heart Association. 1999 Heart and Stroke Statistical Update. Dallas, TX: AHA, 1999, pp 13–4.
- National Institute of Neurological Dis-orders and Stroke. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995533: 1581–7.
- O'Connor RE, McGraw P, Edelsohn L. Thrombolytic therapy for acute ische-mic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med. 199953: 9–14.
- Barsan WG, Brott TG, Broderick JP, et al. Time of hospital presentation in patients with acute stroke. Arch Intern Med. 1993;153:2558–61.
- Alberts MJ, Brass LM, Perry A, Webb D, Dawson DV. Evaluation times for patients with in-hospital strokes. Stroke. 1993;24:1817–22.
- Kothari R, Jausch E, Broderick J, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 199953: 3–8.
- Rosamond WD, Gordon RA, Hirm AR, Hohenhaus SM, Morris DL. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med.19985: 45–51.
- Hadce W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recom-binant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017–25.
- Steiner T, Bluhmke E, Kaste M, et al. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratifi-cation. Cerebrovasc Dis. 1998;8:198–203.
- Hadce W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-con-trolled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet. 1998552: 1245–51.
- Clark WM, Wissman S, Albers G, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. JAMA. 1999;282:2019–26.
- Fisher M, Bogousslavsky J. Further evo-lution toward effective therapy for acute ischemic stroke. JAMA. 1998;279: 1304–6.
- Kothari R, Barsan W, Brott T, Broderick J, Ashbrock S. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke. 1995;26:937–41.
- Sayre MR, Swor RA, Honeycutt LK. Prehospital identification and treat-ment. In: Rapid Identification and Treatment of Acute Stroke. Bethesda, MD: National Institute of Neurological Disorders and Stroke, 1997.
- Pepe PE. The initial links in the chain of recovery for brain attack-access, pre-hospital care, notification and transport. In: Rapid Identification and Treatment of Acute Stroke. Bethesda, MD: Nation-al Institute of Neurological Disorders and Stroke, 1997.
- Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for ather-osclerotic intracranial stenosis. Stroke. 199950: 1065–9.
- Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. JAMA. 1999;282:2003–11.
- Pepe PE, Zachariah BS, Sayre MR, Floccare D. Ensuring the chain of recov-ery for stroke in your community. Acad Emerg Med. 19985: 352–8.
- National Institute of Neurological Dis-orders and Stroke. A systems approach to immediate evaluation and manage-ment of hyperacute stroke. Stroke. 1997;28:1530–40.
- Kothari R, Panicoli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibilty and validi-ty. Ann Emerg Med. 199953: 373–8.
- Zachariah BS, Dunford J, VanCott CC. Dispatch life support and the acute stroke patient: making the right call. In: Rapid Identification and Treatment of Acute Stroke. Bethesda, MD: National Institute of Neurological Disorders and Stroke, 1997.